Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 9, 2025 • 4:30 AM ET

Date/Time Source News Release
04/23/2025 04:36 PM EDT Business Wire Therapeutic Solutions International to Voluntarily Delist
05/16/2024 09:00 AM EDT Business Wire Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases
05/09/2024 09:00 AM EDT Business Wire Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board
03/04/2024 09:00 AM EST Business Wire Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
02/29/2024 09:00 AM EST Business Wire Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product
02/26/2024 09:00 AM EST Business Wire Therapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell Differentiation
01/22/2024 02:58 PM EST Business Wire Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities
01/16/2024 09:00 AM EST Business Wire Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy
01/03/2024 09:00 AM EST Business Wire Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene(TM)
12/11/2023 09:00 AM EST Business Wire Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease
Page